NYSE · KFRC
Kforce Inc.
$58.28+$0.41 (+0.71%)
Kforce Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.62% below the high.
Loading market information…
NASDAQ · ATLN · USD
Stock price, earnings
Quote as of Jul 1, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Atlantic International Corp.’s quoted price sits in the lower half of its reported 52-week range, 82.86% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Atlantic International Corp.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Based in Billerica, Massachusetts, and established in 2013, Atlantic International Corp. (which operated as SeqLL Inc. until its name change in June 2024) underwent a significant corporate change on June 18, 2024, when it was acquired by Lyneer Investments, LLC, via a reverse merger. The company operates within the life sciences sector, providing specialized instrumentation and research services. Its primary focus is on generating innovative scientific assets and proprietary intellectual property across various "omics" disciplines. Central to its offerings is the True Single Molecule Sequencing (tSMS) platform. This advanced technology provides a unique single-molecule approach to DNA and RNA sequencing by directly detecting nucleic acids. It empowers researchers to analyze billions of individual molecules within a single experiment, ensuring the generation of highly accurate and reproducible data. Atlantic International's sophisticated solutions cater to diverse applications, including biomarker discovery and the development of diagnostic assays. Its clientele spans academic institutions (such as universities), governmental research centers, and leading companies in the biotechnology and pharmaceutical industries. The company also fosters key collaborations, including an R&D agreement with the U.S. Department of Justice's Federal Bureau of Investigation to assess the forensic potential of direct RNA sequencing using its tSMS platform, and a partnership with the Weizmann Institute of Science to advance and implement cutting-edge single-molecule technologies.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 02:31 PM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
| Aug 14, 2024 |
| -$0.72 |
| $104.64M |
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$58.28+$0.41 (+0.71%)
Kforce Inc.’s quoted price sits in the upper half of its reported 52-week range, 5.62% below the high.
SGD 0.68-SGD 0.01 (-0.74%)
HRnetGroup Limited’s quoted price sits in the lower half of its reported 52-week range, 12.34% below the high.
$16.23-$0.07 (-0.43%)
HireQuest, Inc.’s quoted price sits in the upper half of its reported 52-week range, 22.12% below the high.
A$0.29A$0.00 (0.0%)
Ashley Services Group Limited’s quoted price sits in the upper half of its reported 52-week range, 17.39% below the high.
CA$1.13-CA$0.03 (-2.59%)
The Caldwell Partners International Inc.’s quoted price sits in the upper half of its reported 52-week range, 8.87% below the high.
$0.20-$0.01 (-2.53%)
GEE Group Inc.’s quoted price sits in the lower half of its reported 52-week range, 28.57% below the high.
$0.22-$0.01 (-6.12%)
Circle8 Group, Inc.’s quoted price sits in the lower half of its reported 52-week range, 95.09% below the high.
$0.06-$0.00 (-2.66%)
Triller Group Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.26% below the high.
